Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroquinone-free skin brightening serum (Melacare) for melasma: randomized split-face double-blind placebo-controlled trial
TCTR20210604008Phase 4Completed
- Sponsor
- N/A
- Start
- Jan 2021
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in melasma (2 arms), sponsored by N/A. Started Jan 2021; status: completed.
02
Conditions
melasma
Beyond the preview
Go deeper on TCTR20210604008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210604008.